BOULDER, Colo.--(BUSINESS WIRE)-- Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in mechanical ventilation and respiratory care devices, today ...

January 22, 2026 /3BL/ – Medtronic, a global leader in healthcare technology, announced verification study results for its investigational Nellcor™ pulse oximetry with Nell-EQ™ intelligent processor ...

DUBLIN, Ireland--(BUSINESS WIRE)-- Covidien (NYSE: COV) today announced CE Mark approval for its Nellcor™ Bedside SpO 2 Patient Monitoring System, PM100N. The system currently is available in the ...

A literature search was done for this briefing in accordance with the interim process and methods statement. This briefing includes the most relevant or best available published evidence relating to ...